Is gliadin harmful from the first morsel?

Digestive and Liver Disease

Volumn 39, Issue 10, 2007, Pages 917-921

  Dieterich, W ^a   Schuppan, D ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLIADIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE ACTIVATION; CELIAC DISEASE; CELLULAR IMMUNITY; DENDRITIC CELL; HUMAN; INNATE IMMUNITY; INTESTINE BIOPSY; MOUTH MUCOSA; PLASMA CELL; TISSUE CULTURE;

EID: 34548393103     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2007.07.160     Document Type: Note

References (34)

1. Dube C., Rostom A., Sy R., Cranney A., Saloojee N., Garritty C., et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 128 Suppl. 1 (2005) S57-S67
2. Wieser H. Chemistry of gliadins. Eur J Gastroenterol Hepatol 3 (1991) 102-107
3. Vader W., Kooy Y., Van Veelen P., De Ru A., Harris D., Benckhuijsen W., et al. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 122 (2002) 1729-1737
4. Marsh M.N. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 102 (1992) 330-354
5. Trier J.S. Celiac sprue. N Engl J Med 325 (1991) 1709-1719
6. AGA Institute Medical Position Statement on the Diagnosis and Management of Celiac Disease. Gastroenterology 131 (2006) 1977-1980
7. Greco L., Romino R., Coto I., Di Cosmo N., Percopo S., Maglio M., et al. The first large population based twin study of coeliac disease. Gut 50 (2002) 624-628
8. Koning F. Celiac disease: caught between a rock and a hard place. Gastroenterology 129 (2005) 1294-1301
9. Maiuri L., Ciacci C., Ricciardelli I., Vacca L., Raia V., Auricchio S., et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 362 (2003) 30-37
10. Di Sabatino A., Ciccocioppo R., Cupelli F., Cinque B., Millimaggi D., Clarkson M.M., et al. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 55 (2006) 469-477
11. Hue S., Mention J.J., Monteiro R.C., Zhang S., Cellier C., Schmitz J., et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21 (2004) 367-377
12. Meresse B., Chen Z., Ciszewski C., Tretiakova M., Bhagat G., Krausz T.N., et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21 (2004) 357-366
13. Lundin K.E., Scott H., Hansen T., Paulsen G., Halstensen T.S., Fausa O., et al. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 178 (1993) 187-196
14. Molberg Ø., McAdam S.N., Koerner R., Quarsten H., Kristiansen C., Madsen L., et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nature Med 4 (1998) 713-717
15. Van de Wal Y., Kooy Y., van Veelen P., Pena S., Mearin L., Papadopoulos G., et al. Selective deamidation by tissue transglutaminase strongly enhances gliading-specific T cell reactivity. J Immunol 161 (1998) 1585-1588
16. Piper J.L., Gray G.M., and Khosla Ch. High selectivity of human tissue transglutaminase for immunoactive gliadin peptides: implications for celiac sprue. Biochemistry 41 (2002) 386-393
17. Dieterich W., Ehnis T., Bauer M., Donner P., Volta U., Riecken E.O., et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature Med 3 (1997) 797-801
18. Dieterich W., Laag E., Schöpper H., Volta U., Ferguson A., Gillett H., et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 115 (1998) 1317-1321
19. Wong R.C., Wilson R.J., Steele R.H., Radford-Smith G., and Adelstein S. A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits. J Clin Pathol 55 (2002) 488-494
20. Halttunen T., and Maki M. Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation. Gastroenterology 116 (1999) 566-572
21. Dieterich W., Trapp D., Esslinger B., Leidenberger M., Piper J., Hahn E., et al. Autoantibodies of patients with coeliac disease are insufficient to block tissue transglutaminase activity. Gut 52 (2003) 1562-1566
22. Sollid L.M., Molberg O., McAdam S., and Lundin K.E. Autoantibodies in coeliac disease: tissue transglutaminase-guilt by association?. Gut 41 (1997) 851-852
23. Picarelli A., Sabbatella L., Di Tola M., Vetrano S., Maffia C., Picchi C., et al. Forty-eight hours of biopsy culture improve the sensitivity of the in vitro gliadin challenge in the diagnosis of celiac disease. Clin Chem 47 (2001) 1841-1843
24. Picarelli A., Di Tola M., Sabbatella L., Anania M.C., Calabro A., Renzi D., et al., Multicentre Organ Culture System Study Group. Usefulness of the organ culture system in the in vitro diagnosis of coeliac disease: a multicentre study. Scand J Gastroenterol 41 (2006) 186-190
25. Carroccio A., Di Prima L., Pirrone G., Scalici C., Florena A.M., Gasparin M., et al. Anti-transglutaminase antibody assay of the culture medium of intestinal biopsy specimens can improve the accuracy of celiac disease diagnosis. Clin Chem 52 (2006) 1175-1180
26. Ellis H.J., and Ciclitira P.J. In vivo gluten challenge in celiac disease. Can J Gastroenterol 15 (2001) 243-247
27. Troncone R., Mazzarella G., Leone N., Mayer M., De Vincenzi M., Greco L., et al. Gliadin activates mucosal cell mediated immunity in cultured rectal mucosa from coeliac patients and a subset of their siblings. Gut 43 (1998) 484-489
28. Vetrano S., Zampaletta U., Anania M.C., Di Tola M., Sabbatella L., Passarelli F., et al. Detection of anti-endomysial and anti-tissue transglutaminase autoantibodies in media following culture of oral biopsies from patients with untreated coeliac disease. Digest Liver Dis (2007) 39
29. Lahteenoja H., Maki M., Viander M., Toivanen A., and Syrjanen S. Local challenge of oral mucosa with gliadin in patients with coeliac disease. Clin Exp Immunol 120 (2000) 38-45
30. Lahteenoja H., Toivanen A., Viander M., Raiha I., Rantala I., Syrjanen S., et al. Increase in T-cell subsets of oral mucosa: a late immune response in patients with treated coeliac disease?. Scand J Immunol 52 (2000) 602-608
31. Lahteenoja H., Maki M., Viander M., Raiha I., Vilja P., Rantala I., et al. Local challenge on oral mucosa with an alpha-gliadin related synthetic peptide in patients with celiac disease. Am J Gastroenterol 95 (2000) 2880-2887
32. Carroccio A., Campisi G., Iacono G., Iacono O.L., Maresi E., di Prima L., et al. Oral mucosa of coeliac disease patients produces antiendomysial and antitransglutaminase antibodies: the diagnostic usefulness of an in vitro culture system. Aliment Pharmacol Ther 25 (2007) 1471-1477
33. Lu F.X., and Jacobson R.S. Oral mucosal immunity and HIV/SIV infection. J Dent Res 86 (2007) 216-226
34. Mitea C., Havenaar R., Drijfhout J.W., Edens L., Dekking L., and Koning F. Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for celiac disease. Gut (2007) [Epub ahead of print]